Study Evaluating Ovasave, an Autologous Cell Therapy, in Patients With Active Crohn's Disease
Clinical trial NCT02327221 · TERMINATED
Trial details
- NCT number
- NCT02327221
- Sponsor
- TxCell
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-11-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.